Expert Review of Anticancer Therapy

Title Publication Date Language Citations
Novel advances in pancreatic cancer treatment2008/06/01English41
Chemotherapy and targeted agents for thymic malignancies2012/05/01English41
Therapy for metastatic melanoma: an overview and update2011/05/01English41
Estrogens, estrogen receptors and melanoma2011/05/01English41
Management of long bone metastases: recommendations from the Italian Orthopaedic Society bone metastasis study group2014/08/25English41
Influence of obesity on breast cancer receptor status and prognosis2009/08/01English41
Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach2005/01/01English41
Pediatric acute myeloid leukemia2012/03/01English40
Role of TGF-β in cancer and the potential for therapy and prevention2004/08/01English40
Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma2015/06/07English40
Targeting RANKL in breast cancer: bone metastasis and beyond2013/02/01English40
Current and future immunotherapies for thyroid cancer2017/12/22English40
From Rapa Nui to rapamycin: targeting PI3K/Akt/mTOR for cancer therapy2006/01/01English40
Detection of lymph node metastases in esophageal cancer2011/04/01English39
Docetaxel in the treatment of advanced non-small-cell lung cancer2008/08/01English39
Maintenance treatment in metastatic breast cancer2008/12/01English39
Inhibition of angiogenesis and invasion in malignant gliomas2007/11/01English39
Epratuzumab in the therapy of oncological and immunological diseases2006/10/01English39
Alemtuzumab2005/01/01English39
Cabozantinib for the treatment of kidney cancer2017/06/26English39
Targeted therapy for metastatic colorectal cancer2018/08/03English39
Intranasal fentanyl: from pharmacokinetics and bioavailability to current treatment applications2010/07/01English39
Esophageal cancer: current and emerging therapy modalities2008/09/01English38
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer2008/01/01English38
TKIs in combination with immunotherapy for hepatocellular carcinoma2023/02/26English38
Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma2012/09/01English38
The origins of urothelial carcinoma2010/06/01English38
Structural and functional analysis of human prostatic acid phosphatase2010/07/01English38
CDK4/6 inhibitors in breast cancer: differences in toxicity profiles and impact on agent choice. A systematic review and meta-analysis2020/12/13English38
Gemcitabine in transitional cell carcinoma of the urothelium2003/02/01English38